Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08IRR
|
|||
| Former ID |
DIB005642
|
|||
| Drug Name |
Org-10490
|
|||
| Indication | Psychotic disorder [ICD-11: 6A20-6A25] | Terminated | [1] | |
| Company |
Organon BioSciences
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H19NO
|
|||
| Canonical SMILES |
CN1CCC2=CC=CC=C2OC3=CC=CC=C3CC1
|
|||
| InChI |
1S/C17H19NO/c1-18-12-10-14-6-2-4-8-16(14)19-17-9-5-3-7-15(17)11-13-18/h2-9H,10-13H2,1H3
|
|||
| InChIKey |
NREYMNFZCFNECP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 83507-02-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ORG 10490: A new antipsychotic drug with 5-HT2 and DA antagonistic properties. ScienceDirect, Volume 6, Issue 2, January 1992, Pages 111. | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.